Krystal Biotech, Inc. (KRYS)
302.03
+1.03
(+0.34%)
USD |
NASDAQ |
Jun 08, 16:00
302.03
0.00 (0.00%)
After-Hours: 19:47
Krystal Biotech Profit Margin (Quarterly) : 48.07% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -- |
| TG Therapeutics, Inc. | 9.65% |
| Vericel Corp. | -9.21% |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Exelixis, Inc. | 34.46% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.88% |
| Return on Assets | 18.20% |
| Return on Invested Capital | 19.72% |
| Gross Profit Margin (Quarterly) | 93.26% |
| Operating Margin (Quarterly) | 46.14% |
| Return on Net Operating Assets | 70.01% |